NDC 43742-1180 Co-infxn

Babesia Microti,Bartonella Henselae,Borrelia Burgdorferi Nosode,Ehrlichia Nosode - View Dosage, Usage, Ingredients, Routes, UNII

Product Information

NDC Product Code:
43742-1180
Proprietary Name:
Co-infxn
Non-Proprietary Name: [1]
Babesia Microti, Bartonella Henselae, Borrelia Burgdorferi Nosode, Ehrlichia Nosode (canine), Encephalitis Nosode, Mycoplasma Pneumoniae, Meningococcus Nosode, Hepatitis B Nosode
Substance Name: [2]
Babesia Microti; Bartonella Henselae; Borrelia Burgdorferi; Ehrlichia Canis; Hepatitis B Virus; Japanese Encephalitis Virus; Mycoplasma Pneumoniae; Neisseria Meningitidis
NDC Directory Status:
Human Otc Drug
Product Type: [3]
ACTIVE PRODUCT INCLUDED in the NDC Directory
Dosage Form:
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route(s): [4]
  • Oral - Administration to or by way of the mouth.
  • Labeler Name: [5]
    Deseret Biologicals, Inc.
    Labeler Code:
    43742
    Marketing Category: [8]
    UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
    Start Marketing Date: [9]
    02-26-2018
    End Marketing Date: [10]
    04-16-2024
    Exclude Flag: [12]
    N
    Code Structure:
    Code Navigator:

    Product Packages

    NDC Code 43742-1180-1

    Package Description: 30 mL in 1 BOTTLE, DROPPER

    Product Details

    What is NDC 43742-1180?

    The NDC code 43742-1180 is assigned by the FDA to the product Co-infxn which is a human over the counter drug product labeled by Deseret Biologicals, Inc.. The generic name of Co-infxn is babesia microti, bartonella henselae, borrelia burgdorferi nosode, ehrlichia nosode (canine), encephalitis nosode, mycoplasma pneumoniae, meningococcus nosode, hepatitis b nosode. The product's dosage form is liquid and is administered via oral form. The product is distributed in a single package with assigned NDC code 43742-1180-1 30 ml in 1 bottle, dropper . This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

    What are the uses for Co-infxn?

    For the temporarily relief of symptoms related to Lyme disease or other co-infections including joint pain, severe headaches, fever, severe muscle aches/pain, flu-like feelings of headache, stiff neck, muscle aches, and change in smell/taste, difficulty chewing, swallowing or speaking, hoarseness of vocal cord problems.****These statements are based upon traditional homeopathic practice. They have not been reviewed by the Food and Drug Administration. For the temporarily relief of symptoms related to Lyme disease or other co-infections including joint pain, severe headaches, fever, severe muscle aches/pain, flu-like feelings of headache, stiff neck, muscle aches, and change in smell/taste, difficulty chewing, swallowing or speaking, hoarseness of vocal cord problems.****These statements are based upon traditional homeopathic practice. They have not been reviewed by the Food and Drug Administration.

    What are Co-infxn Active Ingredients?

    An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
    • BABESIA MICROTI 15 [hp_X]/mL - A species of protozoa infecting humans via the intermediate tick vector IXODES scapularis. The other hosts are the mouse PEROMYSCUS leucopus and meadow vole MICROTUS pennsylvanicus, which are fed on by the tick. Other primates can be experimentally infected with Babesia microti.
    • BARTONELLA HENSELAE 15 [hp_X]/mL - A species of gram-negative bacteria that is the etiologic agent of bacillary angiomatosis (ANGIOMATOSIS, BACILLARY). This organism can also be a cause of CAT-SCRATCH DISEASE in immunocompetent patients.
    • BORRELIA BURGDORFERI 15 [hp_X]/mL - A specific species of bacteria, part of the BORRELIA BURGDORFERI GROUP, whose common name is Lyme disease spirochete.
    • EHRLICHIA CANIS 15 [hp_X]/mL - Species of gram-negative bacteria in the family ANAPLASMATACEAE, causing EHRLICHIOSIS in DOGS. The most common vector is the brown dog tick. It can also cause disease in humans.
    • HEPATITIS B VIRUS 15 [hp_C]/mL - The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum.
    • JAPANESE ENCEPHALITIS VIRUS 15 [hp_X]/mL - A species of FLAVIVIRUS, one of the Japanese encephalitis virus group (ENCEPHALITIS VIRUSES, JAPANESE), which is the etiological agent of Japanese encephalitis found in Asia, southeast Asia, and the Indian subcontinent.
    • MYCOPLASMA PNEUMONIAE 15 [hp_X]/mL - Short filamentous organism of the genus Mycoplasma, which binds firmly to the cells of the respiratory epithelium. It is one of the etiologic agents of non-viral primary atypical pneumonia in man.
    • NEISSERIA MENINGITIDIS 21 [hp_X]/mL - A species of gram-negative, aerobic BACTERIA. It is a commensal and pathogen only of humans, and can be carried asymptomatically in the NASOPHARYNX. When found in cerebrospinal fluid it is the causative agent of cerebrospinal meningitis (MENINGITIS, MENINGOCOCCAL). It is also found in venereal discharges and blood. There are at least 13 serogroups based on antigenic differences in the capsular polysaccharides; the ones causing most meningitis infections being A, B, C, Y, and W-135. Each serogroup can be further classified by serotype, serosubtype, and immunotype.

    Which are Co-infxn UNII Codes?

    The UNII codes for the active ingredients in this product are:

    Which are Co-infxn Inactive Ingredients UNII Codes?

    The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

    * Please review the disclaimer below.

    Product Footnotes

    [1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.

    [2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

    [3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.

    [4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.

    [5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

    [8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

    [9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

    [10] What is the End Marketing Date? - This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.

    [12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".